LIMCH1 and endometrial cancer: LIMCH1 that regulates non-muscle myosin-II activity and suppresses cell migration, (Lin et al., 2017), was previously proposed in lung (Zhang et al., 2019), breast (Bersini et al., 2020), and endometrial cancers (Bell, 2014).